Last update July 18, 2022
Very Low Risk
It is a non-steroidal anti-inflammatory (NSAID), selective inhibitor of cyclooxygenase-2 (COX-2) that is used in the treatment of rheumatoid arthritis and other rheumatic diseases. Topical or oral administration once daily.
It is excreted in breast milk in clinically non-significant amount and no problems have been observed in infants whose mothers took this medication. (Ostensen 1988 y 1983)
Levels in plasma and urine of such infants were undetectable. (Ostensen 1988 y 1983)
Having published less quantity of studies than with other NSAIDs, safer alternatives may be preferable, especially in the neonatal period and in case of prematurity.
Expert authors consider the use of meloxicam to be probably safe during breastfeeding (Hale, Briggs 2015, Østensen 2007, Janssen 2000). The American Academy of Pediatrics rates it as usually compatible with breastfeeding. (AAP 2001)
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2006 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM